The prospect of improved cancer chemotherapy using solid lipid nanoparticles (SLN) as a
drug delivery system is promising. Several obstacles frequently encountered with anticancer …

Solid lipid nanoparticles (SLN) are considered at the forefront of nanotechnology's rapidly
developing field, with several potential applications in drug delivery and research. SLN …

Drug delivery systems have opened new avenues to improve the therapeutic effects of
already-efficient molecules. Particularly, Solid Lipid Nanoparticles (SLNs) have emerged as …

Despite all the advances seen in recent years, the severe adverse effects and low specificity
of conventional chemotherapy are still challenging problems regarding cancer treatment …

More than half of all people diagnosed with cancer receive chemotherapy. Unfortunately,
most chemotherapy drugs cannot tell the difference between a cancer cell and a healthy …

Cancer is one of the major leading causes of mortality in the world. The implication of
nanotherapeutics in cancer has garnered splendid attention owing to their capability to …

Cancer chemotherapeutic agents are often administered systemically. Following systemic
administration, numerous biological factors associated with the tumours influence the …

The efficacy of current standard chemotherapy is suboptimal due to the poor solubility and
short half-lives of chemotherapeutic agents, as well as their high toxicity and lack of …

Recent advancements in drug delivery technologies paved a way for improving cancer
therapeutics. Nanotechnology emerged as a potential tool in the field of drug delivery …

Introduction: Cancer is a leading cause of death worldwide and it is estimated that deaths
from this disease will rise to over 11 million in 2030. Most cases of cancer can be cured with …